Back to Rounds
Series C Round
Funding Details
Antheia Inc. is a next-generation pharmaceutical ingredient manufacturer that utilizes synthetic biology to produce medicines traditionally sourced from plants. The company aims to end drug shortages by creating essential medicines through advanced biosynthesis and genomics. The recent funding will be used to expand the commercialization of Antheia's first product, thebaine, and to launch additional products from their synthetic biology platform.
Confidence Score
Participating Investors
No investors recorded for this funding round.
Related Tweets
No tweets found for this funding round.